VeraDermics IPO: Hair-Loss Drug Developer Targets $200M+ U.S. Listing
U.S.-based biopharmaceutical company VeraDermics Inc. is preparing to enter the public markets with an initial public offering that…
U.S.-based biopharmaceutical company VeraDermics Inc. is preparing to enter the public markets with an initial public offering that…